Viatris (VTRS) Income towards Parent Company (2019 - 2026)

Viatris (VTRS) recorded quarterly Income towards Parent Company of $176.4 million in Q1 2026, up 151.87% quarter-over-quarter from -$340.1 million in Q4 2025, and up 105.8% on a YoY basis from $85.7 million in Q1 2025.

Viatris (VTRS) Income towards Parent Company (2019 - 2026) Analysis & Trends

Viatris' Income towards Parent Company history runs 8 years deep, the most recent figure standing at $176.4 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 105.8% year-over-year to $176.4 million; the TTM figure through Mar 2026 stood at -$296.5 million (up 92.18% YoY), while the FY2025 annual figure was -$3.5 billion, down 454.23% from the prior year.
  • Income towards Parent Company was $176.4 million for Q1 2026 at Viatris, up from -$340.1 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $1.0 billion in Q4 2022 to a low of -$3.0 billion in Q1 2025.
  • Historically, Income towards Parent Company has averaged -$103.7 million across 5 years, with a median of $113.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Income towards Parent Company jumped 483.32% in 2022, then slumped 2770.76% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at $1.0 billion in 2022, then plunged by 175.71% to -$765.6 million in 2023, then surged by 32.54% to -$516.5 million in 2024, then jumped by 34.15% to -$340.1 million in 2025, then jumped by 151.87% to $176.4 million in 2026.
  • The last three Income towards Parent Company figures came in at $176.4 million (Q1 2026), -$340.1 million (Q4 2025), and -$128.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Viatris - - 1.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 176.40 Mn
Dec 31, 2025 -340.10 Mn
Sep 30, 2025 -128.20 Mn
Jun 30, 2025 -4.60 Mn
Mar 31, 2025 -3.04 Bn
Dec 31, 2024 -516.50 Mn
Sep 30, 2024 94.80 Mn
Jun 30, 2024 -326.40 Mn
Mar 31, 2024 113.90 Mn
Dec 31, 2023 -765.60 Mn
Sep 30, 2023 331.60 Mn
Jun 30, 2023 264.00 Mn
Mar 31, 2023 300.40 Mn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 354.30 Mn
Jun 30, 2022 313.90 Mn
Mar 31, 2022 399.20 Mn
Dec 31, 2021 -263.80 Mn
Sep 30, 2021 311.50 Mn
Jun 30, 2021 -279.20 Mn